tiprankstipranks
Samil Pharmaceutical Co., Ltd. (KR:000520)
:000520
South Korea Market
000520
Samil Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Samil Pharmaceutical Co., Ltd. (000520) Financial Statements

― Followers

Samil Pharmaceutical Co., Ltd. Financial Overview

Samil Pharmaceutical Co., Ltd.'s market cap is currently ₩133.83B. The company's EPS TTM is ₩-1763.67; its P/E ratio is -3.96; and it has a dividend yield of 0.96%. Samil Pharmaceutical Co., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 210.37B₩ 219.70B₩ 196.35B₩ 179.68B₩ 134.25B
Gross Profit₩ 67.44B₩ 80.91B₩ 72.21B₩ 67.49B₩ 48.99B
Operating Income₩ -23.94B₩ 113.04M₩ 6.47B₩ 4.02B₩ 399.74M
EBITDA₩ -10.72B₩ 8.66B₩ 10.34B₩ 10.31B₩ 6.15B
Net Income₩ -34.59B₩ -5.63B₩ 1.66B₩ -28.29M₩ -5.35B
Balance Sheet
Cash & Short-Term Investments₩ 6.41B₩ 5.14B₩ 906.14M₩ 1.90B₩ 15.26B
Total Assets₩ 371.60B₩ 395.07B₩ 370.68B₩ 356.70B₩ 226.40B
Total Debt₩ 164.02B₩ 150.08B₩ 175.88B₩ 159.26B₩ 125.51B
Net Debt₩ 157.61B₩ 144.94B₩ 174.97B₩ 157.35B₩ 121.52B
Total Liabilities₩ 238.34B₩ 218.95B₩ 242.85B₩ 230.88B₩ 160.66B
Stockholders' Equity₩ 133.26B₩ 176.12B₩ 127.83B₩ 125.82B₩ 65.75B
Cash Flow
Free Cash Flow₩ -13.52B₩ -3.02B₩ -12.65B₩ -44.50B₩ -31.67B
Operating Cash Flow₩ -6.06B₩ 2.59B₩ 11.75B₩ 4.15B₩ 1.42B
Investing Cash Flow₩ -7.98B₩ -6.36B₩ -19.78B₩ -35.94B₩ -45.31B
Financing Cash Flow₩ 15.29B₩ 7.98B₩ 8.48B₩ 29.71B₩ 31.87B
Currency in KRW

Samil Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Samil Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Samil Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Samil Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >